Today: 30 April 2026
IREN stock drops 7% into MSCI index add — what traders watch before Monday
28 February 2026
2 mins read

IREN stock drops 7% into MSCI index add — what traders watch before Monday

New York, Feb 28, 2026, 14:32 EST — The market is now closed.

  • IREN slipped 7.44% to close at $40.95 on Friday, after moving in a range from $39.54 to $43.09.
  • The stock is set to join the MSCI USA Index when markets close on Feb. 27, prompting index funds to adjust their holdings.
  • Bitcoin edged down near $65,000 on Friday, with traders pulling back from riskier assets.

IREN Limited ended Friday at $40.95, dropping 7.44%, then slid another 0.6% after hours before the weekend break and next week’s U.S. market reopening. Volume jumped to 52.7 million shares, nearly twice Thursday’s 26.7 million.

Bitcoin miner and AI cloud firm IREN moved closer to a long-expected index milestone this month. The company announced it will join the MSCI USA Index after markets close on Feb. 27. Co-CEO Daniel Roberts said the move “reflects the scale and liquidity we have built in the business.” GlobeNewswire

Why now? MSCI’s USA Index tracks large- and mid-cap U.S. stocks and, according to MSCI, captures roughly 85% of the U.S. market’s free-float adjusted value. That’s significant: funds tracking the index typically buy or sell stocks to match any changes in its lineup.

The crypto market hasn’t stood still. Bitcoin dropped 5.98%, landing near $63,650 early Friday, according to Investing.com. Nexo Dispatch’s Iliya Kalchev said the market is “compressing within a liquidity-constrained environment where leverage appetite remains subdued.” Investing.com

Peer performance split. MARA Holdings climbed close to 6% Friday following news of a data-center deal linked to its AI ambitions. TeraWulf, on the other hand, dropped over 9% after its earnings report. Investor’s Business Daily pegged bitcoin at about $65,600 to close out the week.

IREN is working to expand its focus beyond just crypto mining. In its most recent quarterly filing with the SEC on Feb. 5, the company posted $184.7 million in revenue for the quarter ended Dec. 31. Of that, bitcoin mining brought in $167.4 million, while AI cloud services added another $17.3 million. The period ended with a net loss of $155.4 million. The same update disclosed that IREN lined up $3.6 billion in GPU financing tied to a Microsoft contract, and it kept its target for $3.4 billion in annual recurring revenue — ARR, a run-rate metric — by the close of 2026. “We are seeing the strongest demand environment to date,” Roberts said at the time. SEC

But getting added to an index doesn’t promise constant buying. Sometimes, the rebalancing sparks a single day of activity. After that, what happens next for the stock depends on crypto’s moves, appetite for leveraged risk, and whether the company can actually turn AI interest into delivered capacity—without tripping over financing gaps or build delays.

Monday brings a test for IREN following its index reshuffle, as traders eye whether the stock steadies. Bitcoin, too, faces scrutiny to see if it maintains its footing after a weekend that’s typically thin on liquidity.

The week isn’t short on events. ISM Manufacturing PMI lands at 10:00 a.m. EST on the month’s first business day, while the February U.S. jobs report hits Friday, March 6 at 8:30 a.m. ET. Both have the potential to jolt yields and risk sentiment, with knock-on effects for crypto-exposed stocks.

Stock Market Today

  • Textron Q1 Earnings and Revenues Surpass Estimates Amid Market Underperformance
    April 30, 2026, 9:20 AM EDT. Textron (TXT) reported first-quarter earnings of $1.28 per share, beating consensus estimates of $1.17, marking a 9.40% earnings surprise. Revenues reached $3.31 billion, exceeding the $3.25 billion estimate. Despite positive earnings and revenue beats, Textron shares have fallen 13.4% year-to-date, underperforming the S&P 500's 8.6% decline. The aerospace and defense maker's near-term outlook remains mixed, with a Zacks Rank #3 (Hold), suggesting expected performance in line with the market. Consensus estimates forecast $1.46 EPS and $3.61 billion revenue for next quarter. Industry challenges persist, with Aerospace - Defense ranking in the lower 41% of Zacks industries, weighing on stock momentum. Management's upcoming commentary will be crucial for assessing future guidance and investor sentiment.

Latest article

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

30 April 2026
The U.S. dollar fell Thursday after first-quarter GDP growth missed forecasts and core inflation accelerated, complicating the Federal Reserve’s rate outlook. The Dollar Index dropped 0.59% to 98.33, with the dollar hitting session lows against the yen after Japanese officials hinted at intervention. The Fed held rates steady Wednesday but showed division over future cuts. U.S. GDP grew at a 2.0% annualized rate, while core PCE inflation jumped to 4.3%.
QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Chevron stock price faces Monday test after Leviathan shutdown, Hormuz shipping risks
Previous Story

Chevron stock price faces Monday test after Leviathan shutdown, Hormuz shipping risks

AST SpaceMobile stock drops into weekend as Vodafone’s Europe satellite venture goes live
Next Story

AST SpaceMobile stock drops into weekend as Vodafone’s Europe satellite venture goes live

Go toTop